Guanfacine Hydrochloride Guanfacine HCl CAS 29110-48-3 API USP Ọkọlọdị Ọcha Dị Elu

Nkọwa dị mkpirikpi:

Aha: Guanfacine Hydrochloride;Guanfacine HCl

Ọkụ: 29110-48-3

Ọdịdị: White ka Gbanyụọ-White Crystalline ntụ ntụ

Nyocha: 98.0% ~ 102.0% (HPLC na ntọala a mịrị amị)

Ịdị ọcha Chromatographic: ≥99.0%

Guanfacine Hydrochloride bụ Nhọrọ α2A-Adrenoceptor Agonist.Antihypertensive

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye nrụpụta nwere ịdị ọcha dị elu yana ogo kwụsiri ike
Aha kemịkal: Guanfacine Hydrochloride
Nkọwa okwu: Guanfacine HCl
Ọkụ: 29110-48-3
Guanfacine Hydrochloride bụ agonist α2A-adrenoceptor nhọrọ.Antihypertensive
API Ogo dị elu, mmepụta azụmahịa

Njirimara kemịkalụ:

Aha Chemical Guanfacine Hydrochloride
Ụdị okwu Guanfacine HCl
Nọmba CAS 29110-48-3
Nọmba CAT RF-API40
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C9H10Cl3N3O
Ibu molekụla 282.55
Ebe Na-agbaze 211.0 ~ 215.0 ℃
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ntụ ntụ kristal na-acha ọcha ruo na-agbanyụọ
njirimara Infrared absorption;HPLC
Ọnwụ na ihicha ≤0.50%
Ihe fọdụrụ na mgbanye ≤0.10%
Ọla dị arọ ≤20ppm
Nyocha 98.0% ~ 102.0% (HPLC na ntọala a mịrị amị)
Chromatographic ịdị ọcha ≥99.0%
Nlele ọkọlọtọ USP Standard
Ojiji Ngwakọta ọgwụ na-arụ ọrụ (API)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

1

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata Guanfacine Hydrochloride (CAS: 29110-48-3) nwere àgwà dị elu.
Guanfacine hydrochloride na-eme ihe n'etiti agonist a-adrenoceptor.Antihypertensive.Guanfacine hydrochloride, onye na-egbochi ọbara mgbali elu, bụ agonist α2A-adrenoceptor nke nwere Kd nke 31 nM wee gosipụta 60-fold selectivity n'elu α2B-adrenoceptors.Guanfacine na-ebelata ma systolic na ọbara mgbali elu diastolic site na ịgbalite sistemu ụjọ nke etiti α2A norepinephrine autoreceptors, nke na-ebute mbelata mmetụta ọmịiko na-apụ apụ ma si otú a na-ebelata ụda ọmịiko.Ngwa ọgwụgwọ maka guanfacine yiri nke ndị ọzọ na-eme α2-adrenergic agonists na methyldopa.Ọ dị irè dị ka monotherapy na ọgwụgwọ nke ndị ọrịa nwere ọbara mgbali elu dị nwayọọ ma na-agafeghị oke.

Dee ozi gị ebe a ziga anyị ya